Since AorTech’s May trading update the company has continued its run of positive news announcements with a Government grant under the Pivotal Enterprise Resilience Fund (PERF), the issue of a new patent, and most recently, the impending resumption of orders from RUA Medical’s largest customer. We have included the grant income in our financials and had previously reduced our forecasts of FY 2020 revenues, so our valuation remains unchanged.
08 Jun 2020
A run of good news
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
A run of good news
RUA Life Sciences Plc (RUA:LON) | 11.5 0 0.0% | Mkt Cap: 7.14m
- Published:
08 Jun 2020 -
Author:
Andy Smith -
Pages:
4
Since AorTech’s May trading update the company has continued its run of positive news announcements with a Government grant under the Pivotal Enterprise Resilience Fund (PERF), the issue of a new patent, and most recently, the impending resumption of orders from RUA Medical’s largest customer. We have included the grant income in our financials and had previously reduced our forecasts of FY 2020 revenues, so our valuation remains unchanged.